ADN 14.3% 0.8¢ andromeda metals limited

General comments/chat, page-26775

  1. 2,513 Posts.
    lightbulb Created with Sketch. 2056
    This is the kind of calibre of board members that would do wonders for us. Example here is from a pharma stock some of us are in.
    https://au.wallmine.com/asx/rac/officer/1895232/john-cullity
    I like the fact that he has huge subject matter expertise (pharma, for us this would be geo) coupled with an
    impressive background in investment banking.
    Plus, he has done a number of really big commercail deals:
    He has been involved in over 100 licensing and M&A transactions in the life sciences arena, with a combined value in excess of US$10 billion, including the licensing of Antisoma’s oral oncology drug fludarabine by Sanofi, and Kineta’s oncology RIG-I inhibitor by Pfizer.
    If we wonna go big, we gotta think big and get s.b. like that. Imagine where we'd go with a person (equivalent to our industry) on the Board! Who knows one?
 
watchlist Created with Sketch. Add ADN (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.001(14.3%)
Mkt cap ! $27.14M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $92.03K 11.89M

Buyers (Bids)

No. Vol. Price($)
76 31392304 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 12405563 17
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
ADN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.